ep exce consensu algn ep
beat forecast stronger revenu profit despit
increment one-tim headwind invisalign store closur
one-tim freight/reb benefit factor line ad
maintain ep reflect beat well one-tim
factor net off-set moder profit trajectori
balanc year vs previou aggress assumpt
said rais tp ebitda
higher convict street-high estim
revenu ahead plan strength case volume
vs estimate drop asp better expect reflect
fx mix shift deterior america asp line estimate
america volume well ahead strength
line plan growth apac encouragingli elus teen
segment soar vs estimate itero also bright spot
estimate oper margin fell bp mix fx invest
aforement charg bp ahead plan flow
million fund million capit expenditur million
share repurchas remain debt free million cash
reiter outperform initi guidanc admittedli
clean sever one-tim variabl encourag
latest volum asp upsid guidanc exclud stmn benefit
call greater reorgan legal cost initi
one-tim factor importantli make meaning chang
volum asp assumpt balanc year
profit aspir intact op margin investor focu
turn meaning ramp risk competit econom malais
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
manufactur system clear align
therapi intra-or scanner cad/cam digit servic use
dentistri orthodont dental record storag
price apr rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
overal thesi remain improv clinic awar consum sentiment
new technolog enhanc expand geograph teen market focu
drive continu double-digit revenu growth lt improv profit thereon
albeit time scalabl cost base outstand debt enhanc
visibl long-term double-digit ep growth encourag algn
commit grow address market via innov said
sever move part quarter may obfusc underli trend view
still rel healthi importantli make meaning chang volum
asp assumpt balanc year exit vastli better
profit run rate increment cost invest one-tim factor
rearview mirror
term quarter make consider stride across under-penetrated teen
market help increasingli target advertis effort teen case start
strong y/i heel y/i growth tenth consecut
quarter teen volum grew faster adult
remain key sourc growth ou clear align revenu rise
repres algn case shipment note
strength apac brazil major algn doctor-add also
outsid north america meanwhil train nearli doctor apac
half locat china dynam like support go forward
recent open train facil shanghai note continu realiz
intern inher key growth area focu note expect
manufactur facil ziyang china continu ramp plan transit
fabric relev case juarez mexico ziyang next coupl quarter
estim million orthodont case start year algn clear align
solut invisalign treat vs total case start driven
recent launch mandibular advanc offer us among innov
product launch past coupl year view algn on-going innov
continu distanc competitor deemphas impact recent
figur clear align case shipment patient type volum
train new invisalign doctor vs due typic
season includ north latin america
help sustain case growth momentum date boast doctor train
figur doctor train geograph segment total doctor
guidanc review manag unveil quarterli ep guidanc
midpoint well consensu includ one-tim factor repres
estim net benefit still exclud increment invest litig
expens one-tim freight/rebate/sdc charg underli profit improv
sequenti bp assum roughli midpoint rang
top-line perspect manag guid million revenu
predic invisalign case volum growth sdc volum vs
million also expect gross margin rang
sequenti lower one-tim benefit well lower oper expens due
one-tim benefit million straumann settlement gain net estim cost
itero develop agreement well continu invest sale
market note ttm dso day line though expect
improv come quarter
figur guidanc impact unusu item
sdc invest
acknowledg competitor clearli wing remain well ahead
term innov evidenc recent new product announc invisalign first
next-gen itero invisalign go mild-to-moder case expand
address market broadli view room sever player
forecast revenu grow billion increas case
shipment oper margin contract bp y/i continu invest
go-to-market strategi partial off-set lower sg overal ep rise
well major hct peer
forecast revenu rise billion driven increas
case shipment estim oper margin expand bp y/i ep
increas ev/ebitda share close
premium lead dental implant manufactur straumann view
warrant light algn continu abil exceed higher expect
excel innov increasingli effect market strategi
avail
us
compani mention price
